Diversity in clinical trials is often discussed in terms of outreach, representation goals, and recruitment strategies. But one of the most important barriers to participation is frequently overlooked: language. Before a patient can decide whether to participate in a clinical trial, they first need to understand what exactly is being asked of them. If study materials are overly technical, dense, or unclear, participation immediately becomes less accessible to entire communities.
The communication gap
Clinical research depends on trust, which cannot exist without comprehension. Informed consent forms, recruitment advertisements, study protocols, and patient-facing communications are often written for scientific and regulatory audiences, instead of the people expected to read them most closely: patients and caregivers. Medical jargon, complicated sentence structure, and ambiguous terminology can create confusion and intimidation—especially for individuals with lower health literacy, non-native English speakers, or communities historically excluded from research participation.
This communication gap has real, measurable consequences. When patients cannot fully understand what a study involves, they are less likely to enroll, less likely to remain engaged, and less likely to feel confident advocating for themselves throughout the research process. In many cases, the populations researchers most urgently need to reach are the same populations most likely to be unintentionally excluded by inaccessible language.
Communities that have experienced historical mistrust in medical systems may approach clinical research with understandable hesitation. When organizations communicate clearly, respectfully, and transparently, they help create an environment where patients feel informed rather than overwhelmed. Language becomes a bridge instead of a barrier.
Plain language helps improve retention, access, and innovation
Plain language is not about “simplifying” science; it is about making science understandable. There is a difference between reducing complexity and improving clarity. Patients deserve transparent explanations about risks, benefits, procedures, timelines, and expectations without needing a medical dictionary to interpret the information. Simply put: clear communication empowers individuals to make informed decisions and reinforces the ethical foundation of clinical research itself.
The benefits extend beyond enrollment numbers. Diverse clinical trial populations produce stronger science. Treatments and therapies are more effective when they are studied across populations that reflect the real world. Without representative participation, researchers risk developing therapies based on incomplete data—data that may not fully account for differences in genetics, environment, culture, or lived experience. For this reason, improving communication is a scientific necessity.
Retention also improves when patients feel informed throughout the study journey. Participants who clearly understand study procedures, timelines, and expectations are more likely to remain engaged and complete trials successfully. This reduces dropout rates, improves data quality, and strengthens overall study outcomes. Clear communication supports patients at every stage beyond recruitment.
Technology and innovation are rapidly transforming the clinical trial landscape, but accessibility must remain central to those advances. Whether information is delivered through digital consent platforms, patient portals, educational videos, or traditional documents, the goal should remain the same: ensuring every patient has an equal opportunity to understand and participate. True innovation in science communication is about making information more human-centered.
At its core, plain language reflects respect. It acknowledges that every patient, regardless of background or education level, deserves to understand the research they are being asked to join. It signals transparency, prioritizes autonomy, and helps build the trust necessary for meaningful participation. If the future of clinical research is meant to be more inclusive, equitable, and representative, then communication must be treated as foundational infrastructure—not an afterthought.
